The compounder, iDexis, has rejected Novo's claims as "scandalous" and unsubstantiated, and has asked the court to compel the company to produce evidence supporting its allegations, according to court filings seen by Reuters
Conserved pathways involving mitochondrial presequence proteases and DJ-1/PARK7 highlight how regulatory principles first defined in genetically tractable plant models may guide functional validation in neuronal systems
These triggers are prone to non-specific activation by LMW thiols, such as GSH, as well as by thiol-containing proteins, severely limiting their utility in biological applications, particularly in vivo 24,59,63,64
Reed regarding the Semaglutide/Tirzepatide program, please email [email protected]
References FDA: Developing drugs and biological products for weight reduction
No guesswork